Baicalin Inhibits EMT through PDK1/AKT Signaling in Human Nonsmall Cell Lung Cancer

Figure 3

Baicalin reversed EMT of NSCLC. (a–c) Double immunofluorescence staining for E-cadherin and vimentin after treating with baicalin. (d) Protein expression levels of E-cadherin and vimentin after treatment with baicalin. (e, f) The E-cadherin and vimentin expression levels in the tumor tissues of subcutaneously transplanted tumor mice.

(a)

(b)

(c)

(d)

(e)

(f)